National Health Investors (NYSE:NHI) Reaches New 1-Year High – Time to Buy?

National Health Investors, Inc. (NYSE:NHI)’s share price reached a new 52-week high during trading on Thursday . The stock traded as high as $82.92 and last traded at $81.44, with a volume of 237914 shares traded. The stock had previously closed at $81.12.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on NHI. Truist Financial boosted their target price on shares of National Health Investors from $81.00 to $83.00 and gave the company a “buy” rating in a research note on Monday, December 15th. Cantor Fitzgerald set a $85.00 price objective on shares of National Health Investors in a research report on Monday, January 5th. Wells Fargo & Company increased their target price on shares of National Health Investors from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Tuesday, November 25th. National Bankshares set a $85.00 price target on National Health Investors in a research note on Tuesday, January 20th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of National Health Investors in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, National Health Investors currently has an average rating of “Moderate Buy” and a consensus target price of $85.57.

National Health Investors Stock Performance

The stock has a market cap of $3.88 billion, a price-to-earnings ratio of 25.69, a P/E/G ratio of 2.77 and a beta of 0.66. The firm’s 50-day moving average is $78.40 and its two-hundred day moving average is $76.86. The company has a current ratio of 10.64, a quick ratio of 10.64 and a debt-to-equity ratio of 0.74.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Thursday, November 6th. The real estate investment trust reported $1.32 EPS for the quarter, topping the consensus estimate of $1.24 by $0.08. National Health Investors had a return on equity of 10.17% and a net margin of 41.38%.The company had revenue of $83.36 million during the quarter, compared to analyst estimates of $85.66 million. During the same period in the previous year, the business earned $1.03 EPS. National Health Investors’s quarterly revenue was down 1.8% on a year-over-year basis. As a group, sell-side analysts expect that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its holdings in shares of National Health Investors by 305.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,203,492 shares of the real estate investment trust’s stock worth $84,389,000 after purchasing an additional 906,479 shares during the last quarter. Norges Bank acquired a new position in National Health Investors during the second quarter worth $49,775,000. M Holdings Securities Inc. acquired a new position in National Health Investors during the second quarter worth $36,607,000. Balyasny Asset Management L.P. grew its holdings in National Health Investors by 66.9% in the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock valued at $43,121,000 after buying an additional 246,486 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of National Health Investors by 481.3% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust’s stock worth $18,792,000 after acquiring an additional 195,716 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.